NIVEA

Goodbye dark spots,
hello luminous skin

Visible results in just 2 weeks*

Discover our breakthrough innovation that tackles dark-spots,with visible results in just 2 weeks*.


The highly effective Luminous 630® patented formula works at cellular for proven results:


• All types of dark-spots are reduced in 2 weeks*


• Provides protection from dark-spot darkening, reappearance of dark-spots and photo-ageing


• Skin looks and feels moisturised, with the natural luminosity of the skin revealed


• For an even, brighter & luminous complexion

We know dark-spots can have so many causes like sun, ageing and even hormonal factors, which means they can be stubborn. That’s why NIVEA scientists spent 10 years meticulously researching 50,000 possible actives to discover the powerful ingredient Luminous 630®, all to help you reveal the natural luminosity of your skin.


So you can say… goodbye dark-spots. Hello luminous skin!

NIVEA’s highest efficacy in treating dark-spots


The efficacious serum combines the breakthrough ingredient Luminous 630® in its highest concentration with vitamin E and cell-activating hyaluronic acid to visibly reduce all types of darkspots in just 2 weeks*. With regular usage, the hydrating serum re-balances pigmentation to reduce existing dark-spots and prevent the appearance of new ones for even and luminous skin.


The lightweight formula absorbs quickly into the skin with a soft texture. The serum is gentle to the skin and recommended for all skin types.

Achieve protected, smooth & glowing skin with continuous results


NIVEA’s triple-protection formula protects the skin from the sun and photo-ageing, and is effective on all tones. The moisturising day fluid with SPF 50 controls oil in the skin from day 1 and visibly lightens dark-spots in weeks, whilst preventing their reappearance and improving the skin’s texture. Gentle to the skin and recommended for all skin types, including sensitive skin.

Find out more about Luminous 630®

NIVEA


*In-vivo determination of skin condition by clinical and self-grading, STDR-075074C, dated May 2022. To verify contact Consumer.Relations.UK@Beiersdorf.com.